NatthapolSongdejMDMPH
Hematology • Hershey, PAHematologic Oncology, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor of Medicine and Pediatrics
Dr. Songdej is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
B102
Hershey, PA 17033
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Brown UniversityResidency, Internal Medicine/Pediatrics, 2008 - 2012
University of Rochester School of Medicine and DentistryClass of 2008
Certifications & Licensure
PA State Medical License 2012 - 2024
RI State Medical License 2008 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Exceptional Teacher Recognition Penn State College of Medicine, 2018-2020
- Top Teaching Faculty Member in Hematology/Oncology Penn State Health Milton S. Hershey Medical Center Hematology/Oncology Fellowship Program, 2018-2019
- Alpha Omega Alpha University of Rochester School of Medicine and Dentistry, 2008
Publications & Presentations
PubMed
- 35 citationsHematopoietic transcription factor mutations: important players in inherited platelet defects.Natthapol Songdej, A. Koneti Rao
Blood. 2017-05-25 - 15 citationsTranscription Factor RUNX1 Regulates Platelet PCTP (Phosphatidylcholine Transfer Protein): Implications for Cardiovascular Events: Differential Effects of RUNX1 VariantsGuangfen Mao, Natthapol Songdej, Deepak Voora, Lawrence E. Goldfinger, Fabiola Del Carpio-Cano
Circulation. 2017-07-04 - 18 citationsA phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia.Hong Zheng, Shin Mineishi, David F. Claxton, Junjia Zhu, Chenchen Zhao
American Journal of Hematology. 2021-02-01
Press Mentions
Songdej Recognized for 'Exceptional Moments in Teaching'August 12th, 2020
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
